Aptose Biosciences, Inc. (APTO): Price and Financial Metrics
GET POWR RATINGS... FREE!
APTO Stock Price Chart Interactive Chart >
APTO Price/Volume Stats
| Current price | $0.75 | 52-week high | $1.55 |
| Prev. close | $0.74 | 52-week low | $0.43 |
| Day low | $0.74 | Volume | 368,729 |
| Day high | $0.76 | Avg. volume | 272,980 |
| 50-day MA | $0.64 | Dividend yield | N/A |
| 200-day MA | $0.77 | Market Cap | 69.22M |
Aptose Biosciences, Inc. (APTO) Company Bio
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. The company was founded in 1986 and is based in Mississauga, Canada.
Latest APTO News From Around the Web
Below are the latest news stories about APTOSE BIOSCIENCES INC that investors may wish to consider to help them evaluate APTO as an investment opportunity.
Aptose Biosciences Inc. (NASDAQ: APTO): Can A Stock That’s Down -57.04% YTD Still Be Considered In Loss Territory?During the last session, Aptose Biosciences Inc. (NASDAQ:APTO)’s traded shares were 0.38 million, with the beta value of the company hitting 1.54. At the end of the trading day, the stock’s price was $0.58, reflecting an intraday gain of 7.61% or $0.04. The 52-week high for the APTO share is $1.55, that puts it down … Aptose Biosciences Inc. (NASDAQ: APTO): Can A Stock That’s Down -57.04% YTD Still Be Considered In Loss Territory? Read More » |
We Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth CarefullyJust because a business does not make any money, does not mean that the stock will go down. For example, although... |
Aptose Biosciences to Present at Biotech Showcase 2023 ConferenceSAN DIEGO and TORONTO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will participate at the upcoming Biotech Showcase 2023 Conference |
Aptose Biosciences to Present at Biotech Showcase™ 2023 ConferenceSAN DIEGO and TORONTO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will participate at the upcoming Biotech Showcase™ 2023 Conference on Tuesday, January 10th, 2023, at 10:00 a.m. PST in San Francisco, CA. Conference Presentation D |
How did Aptose Biosciences Inc. (APTO) fare last session?A share of Aptose Biosciences Inc. (NASDAQ:APTO) closed at $0.65 per share on Tuesday, down from $0.71 day before. While Aptose Biosciences Inc. has underperformed by -8.45%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, APTO fell by -66.67%, with highs and lows ranging from $2.00 […] |
APTO Price Returns
| 1-mo | 29.31% |
| 3-mo | 36.36% |
| 6-mo | -9.63% |
| 1-year | -42.31% |
| 3-year | -89.07% |
| 5-year | -74.40% |
| YTD | 29.31% |
| 2022 | -57.04% |
| 2021 | -69.18% |
| 2020 | -22.75% |
| 2019 | 196.86% |
| 2018 | -14.73% |
Loading social stream, please wait...